MOLLICA, VERONICA
MOLLICA, VERONICA
CENTRO INTERDIPARTIMENTALE ALMA MATER INSTITUTE ON HEALTHY PLANET
Assegnisti
Addition of Primary Metastatic Site on Bone, Brain, and Liver to IMDC Criteria in Patients With Metastatic Renal Cell Carcinoma: A Validation Study
2021-01-01 Massari F.; Di Nunno V.; Guida A.; Costa Silva C.A.; Derosa L.; Mollica V.; Colomba E.; Brandi G.; Albiges L.
Broad spectrum mutational analysis of chromophobe renal cell carcinoma using next-generation sequencing
2021-01-01 Mollica, Veronica; Franceschini, Tania; Gruppioni, Elisa; Rizzo, Alessandro; Ricci, Costantino; Schiavina, Riccardo; Brunocilla, Eugenio; Ardizzoni, Andrea; Fiorentino, Michelangelo; Giunchi, Francesca; Massari, Francesco
A case of complete response to nivolumab after long-term progression-free survival with tyrosine kinase inhibitor.
2018-01-01 Mollica V, Di Nunno V, Corcioni B, Fiorentino M, Nobili E, Schiavina R, Golfieri R, Brunocilla E, Ardizzoni A, Massari F
Clinical management of a pituitary gland metastasis from clear cell renal cell carcinoma.
2018-01-01 Vincenzo Di Nunno; Veronica Mollica; Beniamino Corcioni; Michelangelo Fiorentino; Elisabetta Nobili; Riccardo Schiavina; Rita Golfieri; Eugenio Brunocilla; Andrea Ardizzoni; Francesco Massari
Combination therapy in advanced urothelial cancer: the role of PARP, HER-2 and mTOR inhibitors
2020-01-01 Mollica V.; Maggio I.; Lopez-Beltran A.; Montironi R.; Cimadamore A.; Cheng L.; Rizzo A.; Giunchi F.; Schiavina R.; Fiorentino M.; Brunocilla E.; Massari F.
Comparative effectiveness of first-line immune checkpoint inhibitors plus tyrosine kinase inhibitors according to IMDC risk groups in metastatic renal cell carcinoma: A meta-analysis
2021-01-01 Rizzo A.; Mollica V.; Santoni M.; Rosellini M.; Marchetti A.; Ricci A.D.; Grilli G.; Greco A.; Montironi R.; Ardizzoni A.; Massari F.
ECOG performance status ≥2 as a prognostic factor in patients with advanced non small cell lung cancer treated with immune checkpoint inhibitors—A systematic review and meta-analysis of real world data
2020-01-01 Dall'Olio F.G.; Maggio I.; Massucci M.; Mollica V.; Fragomeno B.; Ardizzoni A.
The (Eternal) Debate on Microwave Ablation Versus Radiofrequency Ablation in BCLC-A Hepatocellular Carcinoma
2020-01-01 Ricci A.D.; Rizzo A.; Bonucci C.; Tavolari S.; Palloni A.; Frega G.; Mollica V.; Tober N.; Mazzotta E.; Felicani C.; Serra C.; Brandi G.
Exploring the association between metastatic sites and androgen receptor splice variant 7 (AR-V7) in castration-resistant prostate cancer patients: A meta-analysis of prospective clinical trials
2021-01-01 Rizzo A.; Mollica V.; Rosellini M.; Marchetti A.; Ricci A.D.; Fiorentino M.; Battelli N.; Santoni M.; Massari F.
The functioning side of the pancreas: a review on insulinomas
2020-01-01 Maggio I.; Mollica V.; Brighi N.; Lamberti G.; Manuzzi L.; Ricci A.D.; Campana D.
How to choose between percutaneous transhepatic and endoscopic biliary drainage in malignant obstructive jaundice: An updated systematic review and meta-analysis
2020-01-01 Rizzo A.; Ricci A.D.; Frega G.; Palloni A.; De Lorenzo S.; Abbati F.; Mollica V.; Tavolari S.; Di Marco M.; Brandi G.
The human microbiota and prostate cancer: Friend or foe?
2019-01-01 Massari F.; Mollica V.; Di Nunno V.; Gatto L.; Santoni M.; Scarpelli M.; Cimadamore A.; Lopez-Beltran A.; Cheng L.; Battelli N.; Montironi R.; Brandi G.
Immune-based combinations for the treatment of metastatic renal cell carcinoma: a meta-analysis of randomised clinical trials
2021-01-01 Massari F.; Rizzo A.; Mollica V.; Rosellini M.; Marchetti A.; Ardizzoni A.; Santoni M.
Immunohistochemical Expression of Preferentially Expressed Antigen in Melanoma (PRAME) in the Uninvolved Background Testis, Germ Cell Neoplasia in Situ, and Germ Cell Tumors of the Testis
2021-01-01 Ricci, Costantino; Franceschini, Tania; Giunchi, Francesca; Grillini, Marco; Ambrosi, Francesca; Massari, Francesco; Mollica, Veronica; Colecchia, Maurizio; Fiorentino, Michelangelo
Impact of Clinicopathological Features on Survival in Patients Treated with First-line Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors for Renal Cell Carcinoma: A Meta-analysis of Randomized Clinical Trials
2021-01-01 Rizzo A.; Mollica V.; Santoni M.; Ricci A.D.; Rosellini M.; Marchetti A.; Montironi R.; Ardizzoni A.; Massari F.
Impact of HER2 assessment by CISH in urothelial carcinoma: A retrospective single-center experience
2021-01-01 Rizzo A.; Mollica V.; Giunchi F.; Dall'Olio F.G.; Rosellini M.; Marchetti A.; Franceschini T.; Schiavina R.; Brunocilla E.; Fiorentino M.; Ardizzoni A.; Massari F.
Improving IMDC Prognostic Prediction Through Evaluation of Initial Site of Metastasis in Patients With Metastatic Renal Cell Carcinoma
2020-01-01 Di Nunno, Vincenzo; Mollica, Veronica; Schiavina, Riccardo; Nobili, Elisabetta; Fiorentino, Michelangelo; Brunocilla, Eugenio; Ardizzoni, Andrea; Massari, Francesco
Is There a Role for Immunotherapy in Prostate Cancer?
2020-01-01 Rizzo A.; Mollica V.; Cimadamore A.; Santoni M.; Scarpelli M.; Giunchi F.; Cheng L.; Lopez-Beltran A.; Fiorentino M.; Montironi R.; Massari F.
A Meta-Analysis Evaluating Clinical Outcomes of Patients with Renal Cell Carcinoma Harboring Chromosome 9P Loss.
2019-01-01 Di Nunno V, Mollica V, Brunelli M, Gatto L, Schiavina R, Fiorentino M, Santoni M, Montironi R, Caliò A, Eccher A, Milella M, Martignoni G, Brunocilla E, Massari F
Microbiota and prostate cancer
2021-01-01 Rizzo A.; Santoni M.; Mollica V.; Fiorentino M.; Brandi G.; Massari F.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Addition of Primary Metastatic Site on Bone, Brain, and Liver to IMDC Criteria in Patients With Metastatic Renal Cell Carcinoma: A Validation Study | Massari F.; Di Nunno V.; Guida A.; Costa Silva C.A.; Derosa L.; Mollica V.; Colomba E.; Brandi G....; Albiges L. | 2021-01-01 | CLINICAL GENITOURINARY CANCER | - | 1.01 Articolo in rivista | - |
| Broad spectrum mutational analysis of chromophobe renal cell carcinoma using next-generation sequencing | Mollica, Veronica; Franceschini, Tania; Gruppioni, Elisa; Rizzo, Alessandro; Ricci, Costantino; S...chiavina, Riccardo; Brunocilla, Eugenio; Ardizzoni, Andrea; Fiorentino, Michelangelo; Giunchi, Francesca; Massari, Francesco | 2021-01-01 | PATHOLOGY RESEARCH AND PRACTICE | - | 1.01 Articolo in rivista | - |
| A case of complete response to nivolumab after long-term progression-free survival with tyrosine kinase inhibitor. | Mollica V, Di Nunno V, Corcioni B, Fiorentino M, Nobili E, Schiavina R, Golfieri R, Brunocilla E,... Ardizzoni A, Massari F | 2018-01-01 | ANTI-CANCER DRUGS | - | 1.01 Articolo in rivista | - |
| Clinical management of a pituitary gland metastasis from clear cell renal cell carcinoma. | Vincenzo Di Nunno; Veronica Mollica; Beniamino Corcioni; Michelangelo Fiorentino; Elisabetta Nobi...li; Riccardo Schiavina; Rita Golfieri; Eugenio Brunocilla; Andrea Ardizzoni; Francesco Massari | 2018-01-01 | ANTI-CANCER DRUGS | - | 1.01 Articolo in rivista | - |
| Combination therapy in advanced urothelial cancer: the role of PARP, HER-2 and mTOR inhibitors | Mollica V.; Maggio I.; Lopez-Beltran A.; Montironi R.; Cimadamore A.; Cheng L.; Rizzo A.; Giunchi... F.; Schiavina R.; Fiorentino M.; Brunocilla E.; Massari F. | 2020-01-01 | EXPERT REVIEW OF ANTICANCER THERAPY | - | 1.01 Articolo in rivista | - |
| Comparative effectiveness of first-line immune checkpoint inhibitors plus tyrosine kinase inhibitors according to IMDC risk groups in metastatic renal cell carcinoma: A meta-analysis | Rizzo A.; Mollica V.; Santoni M.; Rosellini M.; Marchetti A.; Ricci A.D.; Grilli G.; Greco A.; Mo...ntironi R.; Ardizzoni A.; Massari F. | 2021-01-01 | IMMUNOTHERAPY | - | 1.01 Articolo in rivista | - |
| ECOG performance status ≥2 as a prognostic factor in patients with advanced non small cell lung cancer treated with immune checkpoint inhibitors—A systematic review and meta-analysis of real world data | Dall'Olio F.G.; Maggio I.; Massucci M.; Mollica V.; Fragomeno B.; Ardizzoni A. | 2020-01-01 | LUNG CANCER | - | 1.01 Articolo in rivista | - |
| The (Eternal) Debate on Microwave Ablation Versus Radiofrequency Ablation in BCLC-A Hepatocellular Carcinoma | Ricci A.D.; Rizzo A.; Bonucci C.; Tavolari S.; Palloni A.; Frega G.; Mollica V.; Tober N.; Mazzot...ta E.; Felicani C.; Serra C.; Brandi G. | 2020-01-01 | IN VIVO | - | 1.01 Articolo in rivista | - |
| Exploring the association between metastatic sites and androgen receptor splice variant 7 (AR-V7) in castration-resistant prostate cancer patients: A meta-analysis of prospective clinical trials | Rizzo A.; Mollica V.; Rosellini M.; Marchetti A.; Ricci A.D.; Fiorentino M.; Battelli N.; Santoni... M.; Massari F. | 2021-01-01 | PATHOLOGY RESEARCH AND PRACTICE | - | 1.01 Articolo in rivista | - |
| The functioning side of the pancreas: a review on insulinomas | Maggio I.; Mollica V.; Brighi N.; Lamberti G.; Manuzzi L.; Ricci A.D.; Campana D. | 2020-01-01 | JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION | - | 1.01 Articolo in rivista | - |
| How to choose between percutaneous transhepatic and endoscopic biliary drainage in malignant obstructive jaundice: An updated systematic review and meta-analysis | Rizzo A.; Ricci A.D.; Frega G.; Palloni A.; De Lorenzo S.; Abbati F.; Mollica V.; Tavolari S.; Di... Marco M.; Brandi G. | 2020-01-01 | IN VIVO | - | 1.01 Articolo in rivista | - |
| The human microbiota and prostate cancer: Friend or foe? | Massari F.; Mollica V.; Di Nunno V.; Gatto L.; Santoni M.; Scarpelli M.; Cimadamore A.; Lopez-Bel...tran A.; Cheng L.; Battelli N.; Montironi R.; Brandi G. | 2019-01-01 | CANCERS | - | 1.01 Articolo in rivista | cancers-11-00459.pdf |
| Immune-based combinations for the treatment of metastatic renal cell carcinoma: a meta-analysis of randomised clinical trials | Massari F.; Rizzo A.; Mollica V.; Rosellini M.; Marchetti A.; Ardizzoni A.; Santoni M. | 2021-01-01 | EUROPEAN JOURNAL OF CANCER | - | 1.01 Articolo in rivista | - |
| Immunohistochemical Expression of Preferentially Expressed Antigen in Melanoma (PRAME) in the Uninvolved Background Testis, Germ Cell Neoplasia in Situ, and Germ Cell Tumors of the Testis | Ricci, Costantino; Franceschini, Tania; Giunchi, Francesca; Grillini, Marco; Ambrosi, Francesca; ...Massari, Francesco; Mollica, Veronica; Colecchia, Maurizio; Fiorentino, Michelangelo | 2021-01-01 | AMERICAN JOURNAL OF CLINICAL PATHOLOGY | - | 1.01 Articolo in rivista | - |
| Impact of Clinicopathological Features on Survival in Patients Treated with First-line Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors for Renal Cell Carcinoma: A Meta-analysis of Randomized Clinical Trials | Rizzo A.; Mollica V.; Santoni M.; Ricci A.D.; Rosellini M.; Marchetti A.; Montironi R.; Ardizzoni... A.; Massari F. | 2021-01-01 | EUROPEAN UROLOGY FOCUS | - | 1.01 Articolo in rivista | - |
| Impact of HER2 assessment by CISH in urothelial carcinoma: A retrospective single-center experience | Rizzo A.; Mollica V.; Giunchi F.; Dall'Olio F.G.; Rosellini M.; Marchetti A.; Franceschini T.; Sc...hiavina R.; Brunocilla E.; Fiorentino M.; Ardizzoni A.; Massari F. | 2021-01-01 | PATHOLOGY RESEARCH AND PRACTICE | - | 1.01 Articolo in rivista | - |
| Improving IMDC Prognostic Prediction Through Evaluation of Initial Site of Metastasis in Patients With Metastatic Renal Cell Carcinoma | Di Nunno, Vincenzo; Mollica, Veronica; Schiavina, Riccardo; Nobili, Elisabetta; Fiorentino, Miche...langelo; Brunocilla, Eugenio; Ardizzoni, Andrea; Massari, Francesco | 2020-01-01 | CLINICAL GENITOURINARY CANCER | - | 1.01 Articolo in rivista | - |
| Is There a Role for Immunotherapy in Prostate Cancer? | Rizzo A.; Mollica V.; Cimadamore A.; Santoni M.; Scarpelli M.; Giunchi F.; Cheng L.; Lopez-Beltra...n A.; Fiorentino M.; Montironi R.; Massari F. | 2020-01-01 | CELLS | - | 1.01 Articolo in rivista | - |
| A Meta-Analysis Evaluating Clinical Outcomes of Patients with Renal Cell Carcinoma Harboring Chromosome 9P Loss. | Di Nunno V, Mollica V, Brunelli M, Gatto L, Schiavina R, Fiorentino M, Santoni M, Montironi R, Ca...liò A, Eccher A, Milella M, Martignoni G, Brunocilla E, Massari F | 2019-01-01 | MOLECULAR DIAGNOSIS & THERAPY | - | 1.01 Articolo in rivista | - |
| Microbiota and prostate cancer | Rizzo A.; Santoni M.; Mollica V.; Fiorentino M.; Brandi G.; Massari F. | 2021-01-01 | SEMINARS IN CANCER BIOLOGY | - | 1.01 Articolo in rivista | - |